Protalix BioTherapeutics PLX Institutional Ownership

NYSE PLX

$2.55 -0.02 (-0.78%)

As of: Oct 22, 2026 · 1:21 PM EDT

Institutions by Trading Activity

102 Institutions

Increased 57 55.9%

Unchanged 27 26.5%

Reduced 18 17.6%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

17.96%

▼-2.97 pp QoQ

Shares Held by Institutions

14.47Mn

of 80.57Mn outstanding

▼-14.20% QoQ

Shares Outstanding

80.57Mn

66.10Mn held outside 13F filers

Institutional Investors

102

filed 13F for Jun 2026

▲+2 vs prior quarter

Net Shares Added (QoQ)

-2.39Mn

distributed since last quarter

Value of Holdings

$38.06Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 11, 2026

Protalix BioTherapeutics, Inc. (NYSE:PLX) appeared in the 13F filings of 102 institutional investors for the quarter ended June 30, 2026.

Their combined stake equaled 17.96% of outstanding shares in Q2 2026, down from 20.93% in Q1 2026.
Total holdings of Protalix BioTherapeutics shares fell 14.20% from Q1 2026, and the number of holders rose 64.52% from Q2 2025.
Among the 102 holders of Protalix BioTherapeutics, 57 added to their positions, 18 reduced their stakes and 27 left their positions unchanged.
Altogether, institutional holders owned 14.47Mn PLX shares at the end of Q2 2026, down 2.39Mn from the prior quarter and up 3.02Mn from a year earlier.
BlackRock, Inc. led 13F holders of PLX with 4.05Mn shares as of June 30, 2026, or 5.02% of shares outstanding.
The biggest increases in PLX positions during Q2 2026 came from BlackRock, Inc. (+429.69K shares), Goldman Sachs Group Inc (+224.58K shares), Dimensional Fund Advisors LP (+196.58K shares), AQR Capital Management LLC (+137.33K shares) and Geode Capital Management, LLC (+114.7K shares).
On the other side, among holders that kept a position in Protalix BioTherapeutics, the largest reductions in Q2 2026 came from Morgan Stanley (-250.12K shares), Renaissance Technologies LLC (-128.8K shares), UBS Group AG (-126.89K shares), Orin Green Financial, LLC (-54.43K shares) and Bank of America Corp (-27.18K shares).
Protalix BioTherapeutics' 10 largest institutional shareholders as of Q2 2026 were BlackRock, Inc. (4.05Mn shares), Renaissance Technologies LLC (1.1Mn shares), State Street Corp (983.58K shares), Geode Capital Management, LLC (980K shares), Northern Trust Corp (922.34K shares), Vanguard Portfolio Management LLC (510.64K shares), Stratos Wealth Partners, LTD. (500K shares), Dimensional Fund Advisors LP (493.42K shares), Goldman Sachs Group Inc (475.92K shares) and Marshall Wace, LLP (452.76K shares), per Business Quant data.

Form 13F Holdings

102 Institutional Holders

Report period 30 Jun, 2026

Total shares held 14.47Mn

Of outstanding 17.96%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	BlackRock, Inc.	0002012383	4,046,650	5.02%	▲429,688	+11.88%	$9.43Mn
2	RENAISSANCE TECHNOLOGIES LLC	0001037389	1,096,000	1.36%	▼128,800	-10.52%	$2.55Mn
3	State Street Corp	0000093751	983,582	1.22%	▲10,767	+1.11%	$2.29Mn
4	GEODE CAPITAL MANAGEMENT, LLC	0001214717	979,995	1.22%	▲114,697	+13.26%	$2.28Mn
5	Northern Trust Corp	0000073124	922,340	1.14%	▲36,892	+4.17%	$2.15Mn
6	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	510,639	0.63%	▲78,154	+18.07%	$1.19Mn
7	Stratos Wealth Partners, LTD.	0001612865	500,000	0.62%	0	0.00%	$1.17Mn
8	DIMENSIONAL FUND ADVISORS LP	0000354204	493,424	0.61%	▲196,581	+66.22%	$1.15Mn
9	Goldman Sachs Group Inc	0000886982	475,922	0.59%	▲224,577	+89.35%	$1.11Mn
10	MARSHALL WACE, LLP	0001318757	452,757	0.56%	▲452,757	0.00%	$1.05Mn
11	CITADEL ADVISORS LLC	0001423053	334,227	0.41%	▲334,227	0.00%	$778.75K
12	STRS OHIO	0000820478	296,100	0.37%	▲296,100	0.00%	$689.91K
13	Bank of New York Mellon Corp	0001390777	232,992	0.29%	▲13,685	+6.24%	$542.87K
14	Main Street Financial Solutions, LLC	0001763350	214,100	0.27%	0	0.00%	$498.85K
15	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0001107261	189,100	0.23%	0	0.00%	$440.60K
16	Hillsdale Investment Management Inc.	0001368465	185,711	0.23%	▲185,711	0.00%	$432.71K
17	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0000884546	180,381	0.22%	▲21,070	+13.23%	$420.29K
18	MILLENNIUM MANAGEMENT LLC	0001273087	171,535	0.21%	▲171,535	0.00%	$399.68K
19	AQR CAPITAL MANAGEMENT LLC	0001167557	167,826	0.21%	▲137,333	+450.38%	$391.04K
20	LAZARD ASSET MANAGEMENT LLC	0001207017	165,561	0.21%	▲78,944	+91.14%	$385.76K

Showing 1 to 20 of 102 holders